dacarbazine- dacarbazine injection, powder, for solution
fresenius kabi usa, llc - dacarbazine (unii: 7gr28w0fji) (dacarbazine - unii:7gr28w0fji) - dacarbazine 10 mg in 1 ml - dacarbazine for injection is indicated in the treatment of metastatic malignant melanoma. in addition, dacarbazine for injection is also indicated for hodgkin’s disease as a second-line therapy when used in combination with other effective agents. dacarbazine for injection is contraindicated in patients who have demonstrated a hypersensitivity to it in the past.
dacarbazine medac 200 mg
tzamal bio-pharma ltd - dacarbazine as citrate - powder for solution for inj/inf - dacarbazine as citrate 200 mg/vial - dacarbazine - dacarbazine - decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. further indications for dacarbazine as part of a combination chemotherapy in advanced hodgkin's disease as a second line.
dacarbazine medac 500 mg
tzamal bio-pharma ltd - dacarbazine as citrate - powder for solution for inj/inf - dacarbazine as citrate 500 mg/vial - dacarbazine - dacarbazine - decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. further indications for dacarbazine as part of a combination chemotherapy in advanced hodgkin's disease as a second line.
dacarbazine medac 1000 mg
tzamal bio-pharma ltd - dacarbazine as citrate - powder for solution for inj/inf - dacarbazine as citrate 1000 mg/vial - dacarbazine - dacarbazine - decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. further indications for dacarbazine as part of a combination chemotherapy in advanced hodgkin's disease as a second line.
dacarbazine sandoz dacarbazine 200 mg powder for injection vial
sandoz pty ltd - dacarbazine -
dacarbazine injection, powder, for solution
teva parenteral medicines, inc. - dacarbazine (unii: 7gr28w0fji) (dacarbazine - unii:7gr28w0fji) - dacarbazine 200 mg in 20 ml - dacarbazine for injection is indicated in the treatment of metastatic malignant melanoma. in addition, dacarbazine for injection is also indicated for hodgkin's disease as a secondary-line therapy when used in combination with other effective agents. dacarbazine for injection is contraindicated in patients who have demonstrated a hypersensitivity to it in the past.
dacarbazine injection, powder, for solution
hospira, inc. - dacarbazine (unii: 7gr28w0fji) (dacarbazine - unii:7gr28w0fji) - dacarbazine 10 mg in 1 ml - dacarbazine for injection, usp is indicated in the treatment of metastatic malignant melanoma. in addition, dacarbazine for injection, usp is also indicated for hodgkin's disease as a second-line therapy when used in combination with other effective agents. dacarbazine for injection is contraindicated in patients who have demonstrated a hypersensitivity to it in the past.
dacarbazine medac powder for solution for injection or infusion
medac gmbh - dacarbazine (dacarbazine citrate) - powder for solution for injection or infusion - 200mg
dacarbazine medac 1000 mg
tzamal bio-pharma ltd - dacarbazine as citrate - powder for solution for inj/inf - dacarbazine as citrate 1000 mg/vial - dacarbazine - decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. further indications for dacarbazine as part of a combination chemotherapy in advanced hodgkin's disease as a second line.
dacarbazine medac 200 mg
tzamal bio-pharma ltd - dacarbazine as citrate - powder for solution for inj/inf - dacarbazine as citrate 200 mg/vial - dacarbazine - decarbazine is indicated for the treatment of patients with metastatic malignant melanoma. further indications for dacarbazine as part of a combination chemotherapy in advanced hodgkin's disease as a second line.